3-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-N-[3-(4-chlorophenyl)-3-fluoropropyl]-2-fluoro-6-methylbenzamide
C23H20ClF2N5O — CID 163265712
Data last refreshed: (MolForge compound catalog, from PubChem)
About 3-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-N-[3-(4-chlorophenyl)-3-fluoropropyl]-2-fluoro-6-methylbenzamide
3-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-N-[3-(4-chlorophenyl)-3-fluoropropyl]-2-fluoro-6-methylbenzamide (PubChem CID 163265712) has the molecular formula C23H20ClF2N5O and a molecular weight of 455.90 g/mol. Its IUPAC name is 3-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-N-[3-(4-chlorophenyl)-3-fluoropropyl]-2-fluoro-6-methylbenzamide.
Molecular Properties
| Compound Name | 3-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-N-[3-(4-chlorophenyl)-3-fluoropropyl]-2-fluoro-6-methylbenzamide |
|---|---|
| PubChem CID | 163265712 |
| Molecular Formula | C23H20ClF2N5O |
| Molecular Weight | 455.90 g/mol |
| Exact Mass | 455.13 |
| IUPAC Name | 3-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-N-[3-(4-chlorophenyl)-3-fluoropropyl]-2-fluoro-6-methylbenzamide |
| SMILES | Cc1ccc(-c2ccn3nc(N)nc3c2)c(F)c1C(=O)NCCC(F)c1ccc(Cl)cc1 |
| InChI | InChI=1S/C23H20ClF2N5O/c1-13-2-7-17(15-9-11-31-19(12-15)29-23(27)30-31)21(26)20(13)22(32)28-10-8-18(25)14-3-5-16(24)6-4-14/h2-7,9,11-12,18H,8,10H2,1H3,(H2,27,30)(H,28,32) |
| InChIKey | YQWFKLQPKYCJDE-UHFFFAOYSA-N |
| XLogP | 4.91 |
| TPSA | 85.31 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 455.90 |
| LogP ≤ 5 | 4.91 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 163265712 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.